论文信息 - Overview of regulation of gene therapy in Europe: a current statement including reference to US regulation. - 字舞流文

Overview of regulation of gene therapy in Europe: a current statement including reference to US regulation.

O Cohen-Haguenauer | O. Cohen-Haguenauer

[1] K. Zoon,et al. Regulation of somatic-cell therapy and gene therapy by the food and drug administration. , 1993, The New England journal of medicine.

[2] R. Moen,et al. Report to the NIH Recombinant DNA Advisory Committee on murine replication-competent retrovirus (RCR) assays (February 17, 1993). , 1993, Human gene therapy.

[3] W. Anderson,et al. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. , 1994, Human gene therapy.

[4] G. Sonenshein,et al. NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts , 1992, The Journal of experimental medicine.

[5] R. Mulligan,et al. The basic science of gene therapy. , 1993, Science.

[6] M. Raffeld,et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer , 1992, The Journal of experimental medicine.

[7] P. Noguchi,et al. The safety of retroviral vectors. , 1993, Human gene therapy.

[8] W F Anderson,et al. Improved methods of retroviral vector transduction and production for gene therapy. , 1994, Human gene therapy.